Ginza 1-Chome Clinic: Hybrid MAT Macrophage Activation Therapy

Located in the bustling district of Tokyo, Ginza 1-Chome Clinic is renowned for its "gentle yet highly effective" approach to supportive cancer immunotherapy. The clinic's core technology, Hybrid MAT (Macrophage Activation Therapy), aims to build a solid anti-cancer defense line by activating macrophages—the body's most important "immune scavengers."

Core Technology: Hybrid MAT Dual Activation Protocol

Unlike traditional cell therapies that require massive blood collection and ex vivo culture, Hybrid MAT employs a simpler and safer strategy:

• IAF Plant-Derived IV: A weekly intravenous infusion using high-purity plant components to induce the transformation of internal macrophages into anti-tumor M1 types.
• ARL Oral Activator: Taken daily at home to provide continuous activation signals, ensuring the immune system remains in a high state of alert.
• M1/M2 Balance Regulation: Precisely inhibits M2 macrophages that promote tumor growth while strengthening M1 macrophages that attack tumors, achieving immune remodeling of the microenvironment.

Benefits and Safety

• No Massive Blood Collection: Significantly reduces the physical burden and risk of anemia for patients with advanced cancer.
• Plant-Based Components: High safety profile with very few serious side effects; can be used in conjunction with conventional chemotherapy or radiotherapy.
• Pain Relief Effects: Clinical observations indicate that macrophage activation helps alleviate cancer-related pain and improves the patient's quality of life (QoL).

Medical Consultant's Review

The protocol provided by Ginza 1-Chome Clinic is ideal for patients "seeking low-invasiveness supportive therapy." For those undergoing standard nurturing cares who wish to enhance their immune response, or patients whose physical condition is unsuitable for large-scale cell culture, Hybrid MAT is a high-quality choice that combines evidence-based science with convenience.

【Medical Supporter Guardian Statement】 Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).